EPI Update, August 24, 2012 by unknown
EPI Update for Friday, August 24, 2012 
Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
 
Items for this week’s EPI Update include:  
 Babesiosis: another tick-borne disease   
 Tattoo-associated mycobacterial skin infections 
  2012-13 seasonal influenza vaccine recommendations 
 
Babesiosis: another tick-borne disease   
Summer is the peak season for tick-borne diseases in Iowa. One rare, but important 
tick-borne infection that is not well known is Babesiosis. Babesiosis is caused by the 
parasite Babesia microti, which infects red blood cells. It is endemic in the Northeast 
and the upper Midwest (Minnesota and Wisconsin), and may be present in Iowa. 
 
Babesiosis is asymptomatic in many people, but can cause flu-like illness, hemolytic 
anemia, jaundice, thrombocytopenia (low platelets) and rarely, can result in 
death. Symptoms usually occur a few weeks to months after exposure (but may occur 
several months later, especially in immunocompromised patients). Those at highest risk 
for complications include those without a spleen, the elderly, the immunosuppressed, 
and those with other underlying medical conditions. Babesiosis should therefore be 
considered, especially if risk factors exist such as having spent time outdoors, been 
bitten by ticks, or traveled to endemic areas.   
 
Laboratory diagnosis can be done via blood smears and in Iowa, the State Hygienic 
Laboratory can perform the test.Babesiosis can be treated by a combination of two 
drugs: either atovaquone plus azithromycin OR clindamycin plus quinine. Asymptomatic 
patients typically do not require treatment. 
 
For more information on the diagnosis and treatment of Babesiosis, visit 
www.cdc.gov/parasites/babesiosis/health_professionals/index.html#tx.  
 
Tattoo-associated mycobacterial skin infections 
IDPH has confirmed two cases of skin infections caused by the bacterium 
Mycobacterium chelonae associated with tattoos. Both cases received tattoos in the fall 
of 2011, using the same commercial ink product. No ink in Iowa was available for 
testing; however, these cases were linked to a case in Washington State that had 
received a tattoo using the same brand of ink. An investigation of the ink products was 
conducted by FDA. 
 
Tattoo inks and pigments can be contaminated through: 
 use of contaminated ingredients to make inks 
 use of manufacturing processes that introduce contaminants or allow 
contaminants to survive 
 use of unhygienic practices that contaminate ink bottles or mixing with 
contaminated colors 
 use of non-sterile water to dilute the inks. 
Infections from Mycobacterium chelonae can cause red rash with swelling, possibly 
accompanied by itching or pain in the tattooed area, usually appearing two to three 
weeks after tattooing. The infection does not typically heal without proper treatment by a 
healthcare professional.  
 
For more information, visit 
www.cdc.gov/mmwr/preview/mmwrhtml/mm6133a3.htm?s_cid=mm6133a3_e. 
 
2012-13 seasonal influenza vaccine recommendations 
Shipping of the 2012-13 seasonal flu vaccine has begun. The strains included in this 
year’s formulation are A/California/7/2009 (H1N1)-like, A/Victoria/361/2011 (H3N2)-like, 
and B/Wisconsin/1/2010-like. The latter two antigens differ from those included in the 
last two years’ vaccine. Immunizations should be offered as soon as the vaccine is 
available. The supply of vaccine should meet demand.  
 
All persons 6 months of age and older should be vaccinated.  
 
Those at highest risk of  complications from the flu include children under the age of 5 
years, pregnant women, adults over the age of 65 years, and those with chronic 
conditions like kidney, liver, or blood disorders, endocrine disorders (e.g. diabetes), lung 
diseases (e.g. emphysema, cystic fibrosis, COPD), asthma and weakened immune 
systems. All those at high risk of complications should be vaccinated annually.  
 
Children age 6 months through 8 years old who have received at least one dose of 
H1N1-containing flu vaccine in the past (either one dose of monovalent 2009 H1N1 
vaccine, or seasonal vaccine since July 2010) and has received two doses of any 
seasonal flu vaccine, needs only one dose of this season’s vaccine.  All others should 
receive two dose this season at least four weeks (28 days) apart. 
 
For more information, visit 
www.idph.state.ia.us/ImmTB/Immunization.aspx?prog=Imm&pg=Flu.  
 
Meeting announcements and training opportunities  
None 
 
Have a happy and healthy week! 
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